{"id":"W3129274860","doi":"10.32553/ijmbs.v5i2.1746","title":"RANDOMIZED PHASE III TRIAL COMPARING EPIRUBICIN/ DOXORUBICIN PLUS DOCETAXEL AND EPIRUBICIN/ DOXORUBICIN PLUS PACLITAXEL AS FIRST LINE TREATMENT IN WOMEN WITH ADVANCED BREAST CANCER","year":2021,"lang":"en","type":"article","venue":"International Journal of Medical and Biomedical Studies","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lions Gate Hospital","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Anthracycline; Doxorubicin; Regimen; Chemotherapy; Paclitaxel; Internal medicine; Breast cancer; Neutropenia; Gastroenterology; Urology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002112604,0.001309005,0.002924206,0.0005085742,0.0004267449,0.001070895,0.001075213,0.001431087,0.008322797],"category_scores_gemma":[0.00200388,0.0006900287,0.001370853,0.0005166681,0.00104557,0.0008072897,0.000436757,0.002995243,0.001184352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001003202,"about_ca_system_score_gemma":0.001846379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009835679,"about_ca_topic_score_gemma":0.003236389,"domain_scores_codex":[0.9991761,0.0005413478,0.00004716047,0.0001015501,0.00004927667,0.00008450446],"domain_scores_gemma":[0.9986211,0.0004584658,0.0002753423,0.00008408236,0.00006818081,0.0004928283],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9795991,0.006247878,0.0004862022,0.0003199806,0.0004859327,0.00002800144,0.00002515746,0.0002377432,0.001579713,0.00007456874,0.0006380007,0.01027776],"study_design_scores_gemma":[0.9613535,0.03687225,0.0006996486,0.00001561071,0.0001809213,0.00002334583,0.000008469827,0.00016692,0.0001767621,0.00005244113,0.0004455184,0.000004661807],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747994,0.006643266,0.0008974355,0.001520896,0.001241481,0.008449876,0.002196355,0.0001559086,0.004095326],"genre_scores_gemma":[0.9687017,0.00459891,0.003106165,0.003228126,0.0009433094,0.009493946,0.003069037,0.00004688616,0.006811917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008322797,"threshold_uncertainty_score":0.02784258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04402779330855026,"score_gpt":0.4122844457150511,"score_spread":0.3682566524065009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}